VIGAMOX
NOVARTIS PHARMACEUTICALS CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of VIGAMOX in Canada?
A shortage of VIGAMOX 0.5% is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 30, 2026), but it has not started yet.
Why is VIGAMOX not available?
The reason the manufacturer reported: Demand increase for the drug.
When will VIGAMOX be available again?
The manufacturer's estimated resolution date is February 5, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
SANDOZ MOXIFLOXACIN
SANDOZ CANADA INCORPORATED
Other Products
MOXIFLOXACIN
PRO DOC LIMITEE
TEVA-MOXIFLOXACIN
TEVA CANADA LIMITED
AURO-MOXIFLOXACIN
AURO PHARMA INC
M-MOXIFLOXACIN
MANTRA PHARMA INC
JAMP-MOXIFLOXACIN
JAMP PHARMA CORPORATION
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2027-02-05
~3 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02252260
Strength
0.5%
Dosage Form
SOLUTION
Route
OPHTHALMIC
Active Ingredient
MOXIFLOXACIN
Tier
Unrated
Last Updated
2026-10-30
Reason for Shortage
Demand increase for the drug.
Other Products from NOVARTIS PHARMACEUTICALS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
7.5MG · DIN 02450267
10MG · DIN 02339528
2.5MG · DIN 02369257
5MG · DIN 02339501
5MG · DIN 02425661
2MG · DIN 02425645
3MG · DIN 02425653
140MG · DIN 02487306
70MG · DIN 02479613
0.1% · DIN 00893560
100MG · DIN 02381559
1000MG · DIN 02381567